When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
LLY - Pieris Pharma teams up with Lilly in gastric cancer study
Eli Lilly and Company
Pieris Pharmaceuticals (NASDAQ:PIRS) has entered into a clinical trial collaboration and supply agreement with Eli Lilly (NYSE:LLY) to evaluate the safety and efficacy of combining Pieris' PRS-343, a 4-1BB/HER2 bispecific for HER2-positive tumors, with Lilly's ramucirumab, a VEGFR2 antagonist for multiple types of solid tumors, and paclitaxel for the second-line treatment of patients with HER2-positive gastric cancer in a phase 2 study.
More news on: Pieris Pharmaceuticals, Inc., Eli Lilly and Company, Healthcare stocks news,